Your session is about to expire
← Back to Search
Other
Resistance Exercise + Creatine for Colorectal Cancer
N/A
Recruiting
Led By Ciaran Fairman, PhD
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Individuals receiving active treatment for their cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-weeks
Awards & highlights
Summary
"This trial aims to study the effects of combining creatine supplementation with resistance training in colorectal cancer survivors who are experiencing muscle mass and function decline. The study will compare the effectiveness of a 10-week
Who is the study for?
This trial is for colorectal cancer survivors who have sarcopenia, a condition involving loss of muscle mass and function. Participants should be interested in a 10-week program that includes resistance exercise with or without creatine supplementation.
What is being tested?
The study compares two groups: one doing resistance exercises while taking creatine (EXSUPP) and the other doing just the exercises (EXPLA). The goal is to see if adding creatine improves muscle health after cancer treatment.
What are the potential side effects?
Creatine is generally safe but can sometimes cause weight gain due to water retention, digestive issues like nausea or diarrhea, and muscle cramping. Resistance exercise is typically well-tolerated but may lead to muscle soreness.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently undergoing treatment for my cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Exercise Adherence
Recruitment
Retention
+1 moreSecondary outcome measures
Body Composition
Handgrip Strength
Health-Related Quality of Life
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise + CreatineExperimental Treatment1 Intervention
3 days a week of resistance exercise for 10-weeks + 5g day of creatine monohydrate supplementation
Group II: Exercise + PlaceboPlacebo Group1 Intervention
3 days a week of resistance exercise for 10-weeks + 5g day of placebo (dextrose supplementation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Exercise
2017
Completed Phase 4
~880
Find a Location
Who is running the clinical trial?
University of South CarolinaLead Sponsor
217 Previous Clinical Trials
121,325 Total Patients Enrolled
Ciaran Fairman, PhDPrincipal InvestigatorUniversity of South Carolina
Share this study with friends
Copy Link
Messenger